glp 1 off shortage list UPDATED: FDA lists all doses of Novo's Wegovy as available, signaling potential end to semaglutide supply rout in US GLP-1 Receptor Agonists: Drug Litigation

This article explores the pharmacology of both agents, potential interactions, who might be considered for concurrent use, and the safety considerations and monitoring requirements that any clinician or patient should understand before combining these treatments

Purpose-built for physicians Human, exendin-based GLP-1 receptor agonists similarly reduce CV, renal risk in diabetes A pooled study assessing trials of eight GLP-1 receptor agonists showed all reduce risk for a combined endpoint of major adverse cardiovascular events, regardless of structural homology to human GLP-1, as well as individual CV components

Tan S, Li W, Wang J

A solid choice if heart palpitations are your primary concern

Beyond their role in weight management, GLP-1R agonists have shown neuroprotective and neurotrophic properties, offering potential benefits in reducing neuroinflammation